Aurobindo Pharma USA will acquire Lannett from Lannett Seller Holdco for $250 million on a cash-free, debt-free basis.

Aurobindo Pharma USA acquires Lannett Company LLC for $250 million, expanding U.S. manufacturing capabilities and product ...

The transaction is valued at an enterprise value of $250 million (₹21,850 crore) on a cash-free, debt-free basis, including ...

Hyderabad: In a major strategic move, Aurobindo Pharma Limited has announced that its wholly owned subsidiary, Aurobindo ...

The deal is being carried out on a cash-free, debt-free basis, factoring in standardised working capital levels.

Aurobindo Pharma to acquire US-based Lannett for $250M, gaining a strategic local manufacturing base to offset tariffs and ...

Hyderabad: Amid rising fears of US President Donald Trump imposing tariffs on Indian pharma imports, Aurobindo Pharma is ...

Aurobindo Pharma Ltd. reported a 10.3 per cent year-on-year (YoY) decline in consolidated net profit to Rs 824.2 crore in Q1 ...

Mumbai:Aurobindo Pharma Limited on Monday reported a 10.2 per cent year-on-year (YoY) drop in consolidated net profit to Rs ...

Stocks like Tata Steel, Aurobindo Pharma, Gujarat Gas, Navin Fluorine International, Hitachi Energy, Sagility India, ...

With the stock currently trading at Rs 1,114.50, Aurobindo Pharma experiences a decline in the early trading session.